A Pospective, Single-arm, Multicenter Clinical Trial Evaluating Preoperative Neoadjuvant mFOLFOX6 Chemotherapy in Combination With PD1 Monoclonal Antibody in MSS/pMMR Locally Advanced Rectal Cancer (FIRM Study)
Latest Information Update: 04 Feb 2026
At a glance
- Drugs Serplulimab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Rectal cancer
- Focus Proof of concept; Therapeutic Use
- Acronyms FIRM Study
Most Recent Events
- 27 Jan 2026 Status changed from recruiting to active, no longer recruiting.
- 11 Jan 2026 Results (n=30) presented in American Society of Clinical Oncology Gastrointestinal Cancers Symposium conference, according to Shanghai Henlius Biotech media release.
- 11 Jan 2026 Results presented in the Shanghai Henlius Biotech Media Release.